Neursantys stands at the forefront of non-invasive bioelectronics, addressing neuromotor and neurocognitive conditions lacking widespread pharmacological solutions. Our flagship product platform, NEURVESTA, delivers the world’s first restorative neuroplastic treatment for age-related balance decline, a medical condition that is now known to begin as early as age 40 and affect over 70 million people in Canada and the U.S. alone.